Insider Trading
Filed: 2026-04-10
Key Insights
- The CEO, David James Lennon, sold 14,500 shares of Whitehawk Therapeutics, Inc. (WHWK) at $3.38 per share, potentially indicating some near-term selling pressure on the stock.
- Lennon continues to hold a significant stake of 518,622 shares in the company, suggesting he maintains a positive long-term outlook.
- The sale appears to be a routine transaction to cover tax withholding obligations related to the vesting of restricted stock units, rather than a broader change in the CEO's investment position.